A	C	endYear	fdaYear
Amphotericin B	Leishmaniasis, Visceral	1990	1997
Bromocriptine	Diabetes Mellitus, Non-Insulin-Dependent	1991	2009
celecoxib	Adenomatous Polyposis Coli	1999	1999
Colesevelam	Diabetes Mellitus, Non-Insulin-Dependent	2006	2008
Finasteride	Alopecia	1993	1997
Fluoxetine	Premenstrual dysphoric disorder	1996	2000
Galantamine	Alzheimer's Disease	1989	2001
Methotrexate	Rheumatoid Arthritis	1975	1980
Methotrexate	Psoriasis	1968	1971
Minoxidil	Alopecia	1982	1988
Paroxetine	Hot flushes	1999	2013
Raloxifene	Malignant neoplasm of breast	1997	2007
sildenafil	Hypertension, Pulmonary	1999	2005
Thalidomide	Multiple Myeloma	1998	2006
Zidovudine	Acquired Immunodeficiency Syndrome	1985	2008
Ceftriaxone	Amyotrophic Lateral Sclerosis	1991	-1
Metformin	Malignant neoplasm of breast	2007	-1
Nitric Oxide	Respiratory Distress Syndrome, Adult	2013	-1
Lidocaine	Asthma	1966	-1
gabapentin	Postherpetic neuralgia	1995	2002
gabapentin	Restless Legs Syndrome	1995	2011
pramipexol	Restless Legs Syndrome	1997	2006
milnacipran	Fibromyalgia	2003	2009
topiramate	Obesity	1986	2012
ropinirole	Restless Legs Syndrome	1998	2005
sibutramine	Obesity	1994	1997
topiramate	Obesity	1986	2012
miltefosine	Leishmaniasis	2000	2014
sildenafil	Erectile dysfunction		1998